Xiangzhao Li
Overview
Explore the profile of Xiangzhao Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang J, Zhang Z, Liu H, Liu N, Hu Y, Guo W, et al.
Sci Rep
. 2024 Jun;
14(1):14145.
PMID: 38898042
This study probes the utility of biomarkers for microsatellite instability (MSI) detection and elucidates the molecular dynamics propelling colorectal cancer (CRC) progression. We synthesized a primer panel targeting 725 MSI...
2.
Zhang S, Li N, Wang F, Liu H, Zhang Y, Xiao J, et al.
Pharmacol Res
. 2023 Oct;
197:106974.
PMID: 37898442
Neoadjuvant chemoradiotherapy (nCRT) has become the standard treatment for patients with locally advanced rectal cancer (LARC). However, 20-40% of patients with LARC show little to no response to nCRT. Thus,...
3.
Li X, Zhang S, Zeng J, Song S, Liu X, Kang W, et al.
Pathol Res Pract
. 2023 Jul;
248:154647.
PMID: 37437501
To investigate the heterogeneous expression patterns of four mismatch repair (MMR) proteins in colorectal cancer (CRC) and endometrial cancer (EC), and their effects on the interpretation of immunohistochemical (IHC) results....
4.
Zhou W, Li X, Wu H
Eur J Nucl Med Mol Imaging
. 2023 Apr;
50(10):3149-3150.
PMID: 37093315
No abstract available.
5.
Li G, Zhang T, Yang L, Qin J, Yang Q, Cao Y, et al.
Front Plant Sci
. 2023 Mar;
14:1054571.
PMID: 36968360
Heterosis has been widely used in rice breeding, especially in improving rice yield. But it has rarely been studied in rice abiotic stress, including the drought tolerance, which is becoming...
6.
Sun C, Li B, Wei G, Qiu W, Li D, Li X, et al.
Comput Methods Programs Biomed
. 2022 May;
221:106914.
PMID: 35640390
Background And Objective: Adjuvant chemotherapy is recommended as standard treatment for colorectal cancer (CRC) with stage III according to TNM stage. However, outcomes are varied even among patients receiving similar...
7.
Cheng Y, Tang R, Li X, Wang B, Cheng Y, Xiao S, et al.
J Hepatocell Carcinoma
. 2022 Mar;
9:203-220.
PMID: 35345553
Background: New predictors of the efficacy of hepatocellular carcinoma (HCC) immunotherapy are needed. The ability of a single gene mutation to predict the therapeutic effect of immune checkpoint inhibitors (ICI)...
8.
Zhu Y, Sun P, Wang K, Xiao S, Cheng Y, Li X, et al.
Cancer Cell Int
. 2021 Sep;
21(1):503.
PMID: 34537075
Background: Lenvatinib and lenvatinib-based combination treatments are widely used in patients with unresectable hepatocellular carcinoma (uHCC) in clinical practice, but their curative effect and safety need further study in the...
9.
Huang C, Tang S, Shen D, Li X, Liang L, Ding Y, et al.
Oncol Lett
. 2021 Feb;
21(2):168.
PMID: 33552286
Exosomes carry functional molecules that can regulate cancer progression. Understanding the function of exosomal markers may provide invaluable insights into the mechanism of metastasis in hepatocellular carcinoma (HCC). The aim...
10.
Li X, Liu H, Liang M, Chen H, Liang L
Nan Fang Yi Ke Da Xue Xue Bao
. 2020 Nov;
40(11):1645-1650.
PMID: 33243738
Objective: To explore the clinicopathological features and types of genic mutations in DNA mismatch repair (MMR) in colorectal cancer (CRC). Methods: Immunohistochemistry was used to determine the expression of MMR...